Dendritic cells (DC) are professional antigen-presenting cells whose primar
y function is the initiation of immune response. Based on the finding that
the immune system usually fails to identify and kill cancer cells, DC have
been recently used as vaccines for stimulation of tumour-specific immunity.
This review focuses on pitfalls related to DC-based vaccination against so
lid tumours and on improvement of this immunotherapeutic approach for routi
ne treatment of cancer disease. (C) 2001 Harcourt Publishers Ltd.